价格

drug candidate

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Method for selecting a candidate drug compound
US 2006073518 A1申请人: PEPSCAN SYSTEMS BV优先权: 2003
EP
US
8 件公开
METHOD OF DETERMINING TOXICITY OF AN IMMUNOMODULATORY DRUG FOR USE IN HUMANS
EP 4361637 A3申请人: JACKSON LAB优先权: 2017
CN
EP
US
5 件公开
Method and screening candidate compounds for drug against tumor
US 7125659 B1申请人: CHUGAI PHARMACEUTICAL CO LTD优先权: 1998
US
5 件公开
METHODS FOR DETERMINING THE EFFICACY PROFILE OF A DRUG CANDIDATE
EP 3374499 A1申请人: HOFFMANN LA ROCHE优先权: 2015
CN
EP
US
WO
4 件公开
ANIMAL MODEL FOR DRUG DEVELOPMENT
- EP 3570667 B1
  申请人: NEUTROLIS INC优先权: 2017
  EP
  US
  WO
  4 件公开
- EP 3351094 A1
  申请人: UNIV HAMBURG EPPENDORF优先权: 2017
  EP
METHODS FOR DETERMINING DRUG CANDIDATES
EP 4428869 A1申请人: MOSAIQUES DIAGNOSTICS & THERAPEUTICS AG优先权: 2023
EP
US
WO
4 件公开
Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same
US 9201072 B2申请人: KIM YOON KEUN优先权: 2009
US
4 件公开
FKBP52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction
US 8648044 B2申请人: BAULIEU ETIENNE优先权: 2009
US
4 件公开
Method for screening ameliorants of dry skin caused by atopic dermatitis using bleomycin hydrolase activity as indicator
US 8906629 B2申请人: HIBINO TOSHIHIKO优先权: 2009
US
4 件公开
TARGET FOR SCREENING ANTI-TUMOR DRUG, USE THEREOF AND SCREENING METHOD THEREFOR
US 2024118263 A1申请人: SHENYANG FUYANG PHARMACEUTICAL TECH CO LTD优先权: 2019
CN
US
WO
3 件公开

药物

drug candidate

专利

ANIMAL MODEL FOR DRUG DEVELOPMENT